These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27582549)

  • 1. Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase.
    Song X; Yin S; Zhang E; Fan L; Ye M; Zhang Y; Hu H
    Oncotarget; 2016 Oct; 7(40):65732-65743. PubMed ID: 27582549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis.
    Zhang E; Yin S; Lu X; Ye L; Fan L; Hu H
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29543705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-LAK cell-originated protein kinase is essential for the proliferation of hepatocellular carcinoma SMMC-7721 cells.
    Chen F; Li R; Wang C; Cao L; Wang Y; Yu L
    Cell Biochem Funct; 2013 Dec; 31(8):736-42. PubMed ID: 23526201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrol exerts potent therapeutic effect on lung cancer via directly inactivating T-LAK cell-originated protein kinase.
    Lu S; Ye L; Yin S; Zhao C; Yan M; Liu X; Cui J; Hu H
    Pharmacol Res; 2019 Sep; 147():104366. PubMed ID: 31377221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycycoumarin ameliorates alcohol-induced hepatotoxicity via activation of Nrf2 and autophagy.
    Song X; Yin S; Huo Y; Liang M; Fan L; Ye M; Hu H
    Free Radic Biol Med; 2015 Dec; 89():135-46. PubMed ID: 26169726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
    Kim DJ; Li Y; Reddy K; Lee MH; Kim MO; Cho YY; Lee SY; Kim JE; Bode AM; Dong Z
    Cancer Res; 2012 Jun; 72(12):3060-8. PubMed ID: 22523035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative Effect of Lenvatinib on Human Liver Cancer Cell Lines
    Ogasawara S; Mihara Y; Kondo R; Kusano H; Akiba J; Yano H
    Anticancer Res; 2019 Nov; 39(11):5973-5982. PubMed ID: 31704822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma.
    Xu L; Tong X; Zhang S; Yin F; Li X; Wei H; Li C; Guo Y; Zhao J
    Tumour Biol; 2016 Oct; 37(10):13669-13677. PubMed ID: 27473084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase.
    Zheng M; Luan S; Gao S; Cheng L; Hao B; Li J; Chen Y; Hou X; Chen L; Li H
    Oncotarget; 2017 Jun; 8(24):39143-39153. PubMed ID: 28388576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
    Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
    Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
    Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
    Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DMFC (3,5-dimethyl-
    Xiang J; Wang Z; Liu Q; Li X; Sun J; Fung KP; Liu F
    Apoptosis; 2017 Mar; 22(3):381-392. PubMed ID: 27873035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
    Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
    Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
    Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isatis indigotica induces hepatocellular cancer cell death via caspase-independent apoptosis-inducing factor translocation apoptotic pathway in vitro and in vivo.
    Chung YC; Tang FY; Liao JW; Chung CH; Jong TT; Chen SS; Tsai CH; Chiang EP
    Integr Cancer Ther; 2011 Jun; 10(2):201-14. PubMed ID: 21382959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of glycycoumarin on liver diseases.
    Zhang E; Yin S; Zhao S; Zhao C; Yan M; Fan L; Hu H
    Phytother Res; 2020 Jun; 34(6):1191-1197. PubMed ID: 31840883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
    Diao X; Yang D; Chen Y; Liu W
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noscapine inhibits human hepatocellular carcinoma growth through inducing apoptosis in vitro and in vivo.
    Xu G; Niu Z; Dong J; Zhao Y; Zhang Y; Li X
    Neoplasma; 2016; 63(5):726-33. PubMed ID: 27468876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.